Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
LG H&H Co., Ltd. (051900.KS)
Seoul, KR
LG H&H Co., Ltd. is a prominent South Korean enterprise with a global footprint, primarily engaged in the production and distribution of cosmetics, household essentials, and a diverse range of beverages. Its multifaceted operations are strategically structured into three core divisions: Beauty, Home & Personal Care, and Refreshment. Within its Beauty portfolio, the company markets an extensive selection of cosmetic and personal care items under well-known brand names such as The History of Whoo, O HUI, SU:M37, belif, ISA KNOX, Sooryehan, CODE GLOKOLOR, VONIN, CAREZONE, The Saga of Xiu, BEYOND, Dermalift, CNP, CNP Rx, VDL, Nature Collection, THEFACESHOP, fmgt, DR.Belmeur, and Yehwadam. The Home & Personal Care segment encompasses a comprehensive suite of health and domestic products. This includes oral hygiene items like toothpastes and toothbrushes (e.g., PERIOE, BAMBOO SALT, Saffron, HANIP), personal grooming solutions such as soaps, skincare, and body cleansers (e.g., ONTHEBODY, GENTOLOGY, SILK THERAPY), and various hair care treatments, including shampoos, conditioners, and specialized products (e.g., Elastine, ORGANIST, Reen). Furthermore, this division provides laundry detergents and fabric softeners (e.g., TECH, Super TI, FiJi, Oxygen Clean, AURA, VEILMENT, GENTOLOGY), paper-based goods like diapers and wet wipes (e.g., Toddien), and a range of household cleaning agents such as dish soap and kitchen/bathroom cleaners (e.g., Homestar, SAFE, Jayeonpong, PongPong, Method). The company also manufactures industrial chemical components, including stearin and glycerin. LG H&H's Refreshment division features a broad spectrum of liquid refreshments. This includes sparkling and bottled waters, fruit juices, various lifestyle and sports drinks, as well as teas and coffees. Notable brands in this expansive lineup are Coca-Cola, Coke Zero, Coca-Cola light, Fanta, SPRITE, SPRITE KINCIDER, SCHWEPPES, MilkSoda Ambasa, Dr.Pepper, CANADA DRY, Seagram's, Seagram's THETANSAN, Minute Maid, Minute Maid sparkling, Minute Maid Qoo, Minute Maid Flower, Minute Maid Cocogummy, GEORGIA, Mate Tea of the Sun, Body Health W, GOLD PEAK, POWERADE, TORETA, ViO DIAMOND, ViO DIAMOND EC, ViO JEJU, ViO Soonsoo, Seagram's Mineral Water, GLACEAU vitamin water, Ades, HAITAI htb, and Sunkist. Beyond manufacturing, the firm also maintains its own retail outlets. Established in 1947, LG H&H Co., Ltd. is headquartered in Seoul, South Korea.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.03% | -7.91% | +3.02% | -7.41% | -14.95% | -5.19% | -21.23% | -54.93% | -83.15% | -75.62% | +1,775.46% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 0 | 0 |
| Hold | 13 | -2 |
| Sell | 5 | 0 |
| Strong Sell | 3 | 0 |
-
Revenue growth Household & Personal Products: +3.3%-6.7% Q1'26: -7.1% (vs Q1'25)
-
EPS growth Household & Personal Products: +8.8%-152.9% Q1'26: -99.2% (vs Q1'25)
-
FCF margin FCF growth · Household & Personal Products: +44.8%+6.5% ★ Q1'26: +9.2% (vs Q1'25)
-
EBIT margin Household & Personal Products: +9.9%+2.7% Q1'26: +6.8% (vs Q1'25)
-
ROIC Household & Personal Products: +8.2%+3.7% Q1'26: +7.2% (vs Q1'25)
-
Share dilution Household & Personal Products: +0.2%+0.2% Q1'26: +9,728.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Household & Personal Products: -0.51×0.53× ★ Q1'26: 0.51× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 19 Rev. Ana. 10 EPS Ana. |
Dec 2027 21 Rev. Ana. 16 EPS Ana. |
Dec 2028 18 Rev. Ana. 15 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
5.33T
est: 5.31T (+0.3%)
|
6.09T
est: 6.10T (-0.1%)
|
6.27T
est: 6.27T (0.0%)
|
6.75T
est: 6.71T (+0.6%)
|
7.69T
est: 7.62T (+0.8%)
|
7.84T
est: 7.85T (0.0%)
|
8.09T
est: 8.15T (-0.7%)
|
7.19T
est: 7.32T (-1.8%)
|
6.80T
est: 6.91T (-1.6%)
|
6.81T
est: 6.83T (-0.2%)
|
6.36T
est: 6.45T (-1.5%)
|
6.29T
5.95T – 6.50T
-2.5% YoY
|
6.52T
6.11T – 7.05T
+3.6% YoY
|
6.71T
6.31T – 7.10T
+2.9% YoY
|
| EBITDA |
809.58B
est: 696.94B (+16.2%)
|
1.01T
est: 800.01B (+26.7%)
|
1.02T
est: 822.43B (+24.2%)
|
1.12T
est: 879.63B (+27.7%)
|
1.35T
est: 999.62B (+35.1%)
|
1.39T
est: 1.03T (+35.0%)
|
1.47T
est: 1.07T (+37.6%)
|
713.62B
est: 959.44B (-25.6%)
|
757.03B
est: 906.69B (-16.5%)
|
589.51B
est: 741.75B (-20.5%)
|
409.60B
est: 701.01B (-41.6%)
|
683.53B
646.03B – 706.33B
-2.5% YoY
|
708.38B
663.87B – 766.13B
+3.6% YoY
|
728.96B
686.01B – 771.17B
+2.9% YoY
|
| EBIT |
677.65B
est: 500.68B (+35.3%)
|
772.60B
est: 574.72B (+34.4%)
|
875.03B
est: 590.83B (+48.1%)
|
966.14B
est: 631.92B (+52.9%)
|
1.10T
est: 718.12B (+53.0%)
|
1.13T
est: 739.19B (+52.4%)
|
1.19T
est: 767.49B (+55.7%)
|
425.64B
est: 689.25B (-38.2%)
|
487.16B
est: 651.36B (-25.2%)
|
333.90B
est: 483.65B (-31.0%)
|
169.61B
est: 457.09B (-62.9%)
|
445.69B
421.24B – 460.56B
-2.5% YoY
|
461.90B
432.87B – 499.55B
+3.6% YoY
|
475.32B
447.31B – 502.84B
+2.9% YoY
|
| Net Income |
460.35B
est: 492.48B (-6.5%)
|
568.22B
est: 630.24B (-9.8%)
|
606.65B
est: 637.92B (-4.9%)
|
682.74B
est: 712.24B (-4.1%)
|
778.10B
est: 821.41B (-5.3%)
|
797.63B
est: 821.46B (-2.9%)
|
844.52B
est: 891.92B (-5.3%)
|
236.57B
est: 445.90B (-46.9%)
|
142.76B
est: 278.02B (-48.7%)
|
189.13B
est: 302.86B (-37.5%)
|
-100.10B
est: 148.86B (-167.2%)
|
191.37B
118.29B – 253.21B
+28.6% YoY
|
246.44B
155.60B – 339.61B
+28.8% YoY
|
253.56B
234.14B – 272.65B
+2.9% YoY
|
| SGA |
1.64T
est: 1.69T (-3.0%)
|
1.95T
est: 1.94T (+0.6%)
|
2.05T
est: 2.00T (+2.9%)
|
2.11T
est: 2.13T (-1.4%)
|
2.56T
est: 2.43T (+5.6%)
|
2.59T
est: 2.50T (+3.8%)
|
2.70T
est: 2.59T (+4.2%)
|
2.27T
est: 2.33T (-2.4%)
|
2.09T
est: 2.20T (-4.8%)
|
2.06T
est: 2.13T (-3.0%)
|
1.89T
est: 2.01T (-6.1%)
|
1.96T
1.85T – 2.03T
-2.5% YoY
|
2.03T
1.90T – 2.20T
+3.6% YoY
|
2.09T
1.97T – 2.21T
+2.9% YoY
|
| EPS |
27,467.00
est: 29,391.55 (-6.5%)
|
33,905.00
est: 37,612.80 (-9.9%)
|
36,184.00
est: 38,071.41 (-5.0%)
|
40,746.00
est: 42,506.72 (-4.1%)
|
46,436.00
est: 49,021.98 (-5.3%)
|
47,602.00
est: 49,024.81 (-2.9%)
|
50,401.00
est: 53,230.11 (-5.3%)
|
14,118.00
est: 26,611.07 (-46.9%)
|
8,519.64
est: 16,592.39 (-48.7%)
|
11,287.00
est: 18,047.54 (-37.5%)
|
-5,973.69
est: 8,870.83 (-167.3%)
|
11,403.79
7,048.94 – 15,088.97
+28.6% YoY
|
14,685.51
9,272.61 – 20,237.94
+28.8% YoY
|
15,110.10
13,952.60 – 16,247.54
+2.9% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-29 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-28 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-27 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-24 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-23 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-22 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-21 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-20 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-17 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-16 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-15 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-14 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Heon-Yeong Park | Executive Director of Public Relations Division | 1B | — |
| Myoung Seok Lee | Chief Financial Officer, CRO & Inside Director | — | male |
| Sun-joo Lee | Chief Executive Officer | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 051900.KS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
